0001209191-16-138301.txt : 20160823 0001209191-16-138301.hdr.sgml : 20160823 20160823161029 ACCESSION NUMBER: 0001209191-16-138301 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160822 FILED AS OF DATE: 20160823 DATE AS OF CHANGE: 20160823 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cerulean Pharma Inc. CENTRAL INDEX KEY: 0001401914 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204139823 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-996-4300 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Tempo Pharmaceuticals Inc DATE OF NAME CHANGE: 20070604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Senderowicz Adrian CENTRAL INDEX KEY: 0001616230 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36395 FILM NUMBER: 161847348 MAIL ADDRESS: STREET 1: C/O PUMA BIOTECHNOLOGY, INC. STREET 2: 10880 WILSHIRE BOULEVARD, SUITE 2150 CITY: LOS ANGELES STATE: CA ZIP: 90024 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-08-22 0 0001401914 Cerulean Pharma Inc. CERU 0001616230 Senderowicz Adrian C/O CERULEAN PHARMA INC. 35 GATEHOUSE DRIVE WALTHAM MA 02451 0 1 0 0 SVP, Chief Medical Officer Stock Option (right to buy) 1.14 2016-08-22 4 A 0 100000 0.00 A 2026-08-21 Common Stock 100000 100000 D This option was granted on August 22, 2016. The option is scheduled to vest as to 25% of the shares on the six-month anniversary of August 22, 2016 and as to an additional 25% of the original number of shares at the end of each six-month period of continuous service thereafter until August 22, 2018. /s/ Alejandra Carvajal, as attorney-in-fact for Adrian Senderowicz 2016-08-23